These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16185174)

  • 1. Pharmacokinetics of intravenously administered levofloxacin in men and women.
    Overholser BR; Kays MB; Lagvankar S; Goldman M; Mueller BA; Sowinski KM
    Pharmacotherapy; 2005 Oct; 25(10):1310-8. PubMed ID: 16185174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
    Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
    Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats.
    Albarellos GA; Ambros LA; Landoni MF
    J Vet Pharmacol Ther; 2005 Aug; 28(4):363-9. PubMed ID: 16050816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levofloxacin pharmacokinetics in children.
    Chien S; Wells TG; Blumer JL; Kearns GL; Bradley JS; Bocchini JA; Natarajan J; Maldonado S; Noel GJ
    J Clin Pharmacol; 2005 Feb; 45(2):153-60. PubMed ID: 15647407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered steady state pharmacokinetics of levofloxacin in adult cystic fibrosis patients receiving calcium carbonate.
    Pai MP; Allen SE; Amsden GW
    J Cyst Fibros; 2006 Aug; 5(3):153-7. PubMed ID: 16481224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers.
    Chow AT; Fowler C; Williams RR; Morgan N; Kaminski S; Natarajan J
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2122-5. PubMed ID: 11408234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the pharmacokinetic disposition of levofloxacin in stallions after intravenous and intramuscular administration.
    Goudah A; Abo El-Sooud K; Shim JH; Shin HC; Abd El-Aty AM
    J Vet Pharmacol Ther; 2008 Oct; 31(5):399-405. PubMed ID: 19000258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE; Golden JA; McIver M; Zurlinden E
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levofloxacin pharmacokinetics in ESRD and removal by the cellulose acetate high performance-210 hemodialyzer.
    Sowinski KM; Lucksiri A; Kays MB; Scott MK; Mueller BA; Hamburger RJ
    Am J Kidney Dis; 2003 Aug; 42(2):342-9. PubMed ID: 12900817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics/pharmacodynamics of levofloxacin 750 mg once daily in young women with acute uncomplicated pyelonephritis.
    Nicolle L; Duckworth H; Sitar D; Bryski L; Harding G; Zhanel G
    Int J Antimicrob Agents; 2008 Mar; 31(3):287-9. PubMed ID: 18155885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary bactericidal activity of single doses (250, 500, 750 and 1000 mg) of levofloxacin against fluoroquinolone-resistant strains of Escherichia coli.
    Stein GE; Schooley SL; Nicolau DP
    Int J Antimicrob Agents; 2008 Oct; 32(4):320-5. PubMed ID: 18715762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levofloxacin secretion in breast milk: a case report.
    Cahill JB; Bailey EM; Chien S; Johnson GM
    Pharmacotherapy; 2005 Jan; 25(1):116-8. PubMed ID: 15767227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries.
    Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C
    J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-related differences in the pharmacokinetics of oral ciprofloxacin.
    Overholser BR; Kays MB; Forrest A; Sowinski KM
    J Clin Pharmacol; 2004 Sep; 44(9):1012-22. PubMed ID: 15317829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state pharmacokinetics and pharmacodynamics of meropenem in hospitalized patients.
    Cheatham SC; Kays MB; Smith DW; Wack MF; Sowinski KM
    Pharmacotherapy; 2008 Jun; 28(6):691-8. PubMed ID: 18503396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of intravenous and oral levofloxacin in critically ill adults in a medical intensive care unit.
    Rebuck JA; Fish DN; Abraham E
    Pharmacotherapy; 2002 Oct; 22(10):1216-25. PubMed ID: 12389872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in CYP3A activity using intravenous and oral midazolam.
    Chen M; Ma L; Drusano GL; Bertino JS; Nafziger AN
    Clin Pharmacol Ther; 2006 Nov; 80(5):531-8. PubMed ID: 17112809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
    Czock D; Hüsig-Linde C; Langhoff A; Schöpke T; Hafer C; de Groot K; Swoboda S; Kuse E; Haller H; Fliser D; Keller F; Kielstein JT
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1263-8. PubMed ID: 17699357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.